For more than 10 years, the University at Buffalo's HIV Clinical Pharmacology Research Program has helped fight the global AIDS epidemic by hosting visiting pharmaceutical scientists from countries ...
In a major collaborative effort, researchers at the University of Nebraska Medical Center and the Lewis Katz School of Medicine at Temple University have, for the first time, eliminated ...
The University of Liverpool has launched an i-phone application, HIV iChart,that provides healthcare professionals and HIV patients with instant and easy access to information about drug interactions.
The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program ...
Patients living with HIV are used to taking a battery of medicine every day to treat the virus, but a new breakthrough from Omaha researchers could change that forever.Doctors at the University of ...
The alternative text for this image may have been generated using AI. New drugs have transformed the treatment of viral infections — in particular, HIV — in the past two decades. Our interviewees this ...
HIV-1 and HIV-2 are both types of HIV. While both weaken the immune system, HIV-2 develops more slowly and has a lower transmission rate than HIV-1. HIV-2 is resistant to some medications that can ...
BUFFALO, N.Y. – For more than 10 years, the University at Buffalo's HIV Clinical Pharmacology Research Program has helped fight the global AIDS epidemic by hosting visiting pharmaceutical scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results